How well will Biogen's Alzheimer's drug Aduhelm perform in the real world? This study is set to find out

While all eyes are on Biogen’s FDA-required Aduhelm trial that will determine whether the treatment actually aids Alzheimer’s disease patients, the company is involved in another real-world study in the works assessing its worth in an array of people coping with the memory-robbing disease.